MAGNETOM World
MAGNETOM World
  1. MAGNETOM World
  2. Virtual 11th MAGNETOM World Summit
  3. 11th MAGNETOM World Summit
  4. Men’s Health and Screening

Men’s Health and Screening

Selecting the Right Patients in the Age of MRI Prostate Cancer Screening

Masoom Haider (Toronto General Hospital, Canada)

Productivity and Short Examination Protocols with GO Prostate and the Prostate Dot Engine

Mukesh G. Harisinghani (Massachusetts General Hospital, Boston, MA, USA)

Prostate AI – Performance in Clinical Practice

Moon-Hyung Choi (Eunpyeong St. Mary's Hospital. The Catholic University of Korea, Seoul, South Korea)

Active Surveilance with MRI

Kartik S. Jhaveri (University Health Network, Toronto, Canada)

Efficient, Fast and Precise MR-guided Biopsies with the Soteria RMC

Anshuman Panda (Mayo Clinic, Phoenix, AZ, USA)

New Minimal-invasive, Image-guided Treatment Options for Low-grade Prostate Cancer

Jurgen Fütterer (Radboud UMC, Nijmegen, The Netherlands)

Managment of Advanced Disease

Chen Min (Beijing Hospital, The National Center of Gerontology, China)

Unmet Needs in Prostate MRI. Where is the Field Heading to?

Anwar R. Padhani (Mount Vernon Cancer Centre, London, UK)

Graphic Recordings of lectures and sessions

Men’s Health and Screening

Men’s Health and Screening 

The herein illustrated statements made by Siemens Healthineers’ customers are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.

1

Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

2

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens Healthineers.

3

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.

4

Work in progress: the application is currently under development and is not for sale in the U.S. and in other countries. Its future availability cannot be ensured. Note: This feature may not be available in all regions/countries at the time of publication.

5

The product is not for sale in the U.S. Its future availability cannot be guaranteed.